FBR Capital Starts MedEquities Realty Trust (MRT) at Outperform

October 24, 2016 6:36 AM EDT
Get Alerts MRT Hot Sheet
Price: $11.32 -0.79%

Rating Summary:
    5 Buy, 1 Hold, 1 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 22 | Down: 32 | New: 34
Trade MRT Now!
Join SI Premium – FREE

Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here.

FBR Capital initiates coverage on MedEquities Realty Trust (NYSE: MRT) with a Outperform rating and a price target of $14.00.

Analyst Bryan Maher commented, "We are initiating coverage of MedEquities Realty Trust, Inc. (MRT) with an Outperform rating following its recently completed IPO. MedEquities is a selfmanaged REIT that invests in a diversified mix of healthcare facilities with an emphasis on acute care and post–acute care facilities. It currently owns 24 facilities (2,345 licensed beds) located predominantly in Texas, California, and Nevada. Senior management has over 30 years of experience and a successful track record investing in healthcare properties and, we expect, will utilize its significant industry relationships to source non-marketed facilities to acquire. In fact, the current identified pipeline for acquisitions is ~$600 million; we are modeling for the REIT to close on $400 million in properties in 2017–2018. Compared with its current $500 million portfolio, this is significant relative growth. Management believes the opportunity for higher risk-adjusted returns lies in the acute and post-acute (SNF) sectors with targeted cap rate yields at or above 8.75%. We believe management's track record in its first two years of operation (since July 2014) gives credibility to its growth plan, and, as such, we initiate at Outperform with a $14 price target."

For an analyst ratings summary and ratings history on MedEquities Realty Trust click here. For more ratings news on MedEquities Realty Trust click here.

Shares of MedEquities Realty Trust closed at $11.72 yesterday.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories

Analyst Comments, New Coverage

Related Entities

Definitive Agreement, IPO

Add Your Comment